In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: Stem cell factor requirement and effects of previous chemotherapy

Haematologica

Volumn 84, Issue 5, 1999, Pages 390-396

  Ferrero, Dario ^a   Cherasco, Cristina ^a   Ortolano, Barbara ^a   Giaretta, Fulvia ^a   Bruno, Benedetto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

CD38 negative progenitors; Chemotherapy; Complement cytotoxicity; Stem cell factor

Indexed keywords

CD33 ANTIGEN; CD38 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; STEM CELL FACTOR;

ARTICLE; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT GM; CULTURE MEDIUM; DRUG EXPOSURE; GROWTH REGULATION; GROWTH STIMULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIVISION; CELL SURVIVAL; HEMATOPOIETIC STEM CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; STEM CELL FACTOR;

EID: 0032850711     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Eaves CJ, Cashman JD, Eaves AC. Methodology of long term culture of human hemopoietic cells. J Tiss Cult Meth 1991; 13:55-62.
2. Carlo Stella C, Cazzola M, De Fabritiis P, et al. CD34 positive cells: biology and clinical relevance. Haematologica 1995; 80:367-87.
3. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74:1563-70.
4. Gordon MY, Hibbin JA, Kearney LU, Gordon-Smith EC, Goldman JM. Colony formation by primitive hematopoietic progenitors in cocultures of bone marrow and stromal cells. Br J Haematol 1985; 60:129-36.
5. Brems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cells assay. Leukemia 1994; 8:1095-104.
6. Petzer AL, Hogge DE, Lansdorp P M, Reid DS, Eaves CJ. Self-renewal of primitive human hematopoietic cells (long-term culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93:1470-4.
7. Leary AG, Zeng HQ, Clark S, Ogawa M. Growth factor requirements for survival in GO and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 1992; 89:4013-7.
8. Leary AG, Ikebuchi K, Hirai Y, et al. Synergism between interleukin 6 and interleukin 3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin 1a. Blood 1988; 71:1759-63.
9. Rowley SD, Sharkis SL, Hattenburg C, Sensenbrenner LL. Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity. Blood 1987; 69:804-8.
10. Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78:1-19.
11. Brandt J, Baird N, Lu L, Srouor E, Hoffman R. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 1988; 82:1017-27.
12. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and their light scatter properties. J Exp Med 1989; 169:1721-31.
13. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generation of hematopoietic colonies derived from single, non lineage-committed CD34+ CD38-progenitor cells. Blood 1991; 77:1218-27.
14. Benedetti G, Bondesan P, Caracciolo D, et al. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin. Exp Ematol 1994; 22:166-73.
15. Huang S, Terstappen LWMM. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38-hematopoietic stem cells. Blood 1994; 83: 1515-26.
16. Sauvageau G, Lansdorp PM, Eaves CJ, et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994; 91:12223-7.
17. Tarella C, Ferrero D, Caracciolo D, Badoni R, Bellone G, Gallo E. Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors. J Clin Lab Immunol 1988; 25: 185-90.
18. Ferrero D, Broxmeyer HE, Pagliardi GL, Venuta S, Lange B, Rovera G. Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow. Proc Natl Acad Sci USA 1983; 80:4114-8.
19. Platzer E, Weite K, Lu L, et al. Biological activities of a human pluripotent hemopoietic colony-stimulating factor on normal and leukemia cells. J Exp Med 1985; 162:1788-801.
20. Mochizuki DY, Eisenman JA, Conlon PJ, Larsen AD, Tushinski RJ. Interleukin 1a regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci USA 1987; 84:5267-71.
21. Taswell C. Limiting dilution assay for the determination of immunocompetent cell frequency. J Immunol 1981; 126:1614-9.
22. Mc Niece IK, Langley KE, Zsebo KM. Recombinant human stem cell factor (rhSCF) synergizes with GM-CSF, G-CSF, IL3 and EPO to stimulate human progenitor cells of myeloid and erythroid lineages. Exp Hematol 1991; 19:226-31.
23. Petzer AL, Zardstra PW, Piret JM, Eaves CJ. Different cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 1996; 183:2551-8.
24. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 1997; 94:4698-703.
25. Verfaillie C, Blakolmer K, Mc Glave P. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 1990; 12:509-20.
26. Domenech J, Linassier C, Gihana E, et al. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. Blood 1995; 85:3320-7.
27. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Inter Med 1985; 102:596-602.
28. Gonzalez-Requejo A, Madero L, Diaz MA, et al. Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 1998; 101:104-10.
29. Sampol Mayol A, Besalduch Vital J, Galmes Llodra A, et al. CD34+ cell dose and CD33-subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation. Haematologica 1998; 83:489-95.
30. Olivieri A, Offidani M, Montanari M, et al. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 1998; 83:329-37.